We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.52B
AUM Growth
+$6.76M
Cap. Flow
+$42.3M
Cap. Flow %
2.79%
Top 10 Hldgs %
27.44%
Holding
435
New
29
Increased
184
Reduced
112
Closed
75

Top Buys

1
BMY icon
Bristol-Myers Squibb
BMY
+$21.1M
2
FSLR icon
First Solar
FSLR
+$15.7M
3
UTHR icon
United Therapeutics
UTHR
+$14.9M
4
HUM icon
Humana
HUM
+$14.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$13.4M

Top Sells

1
KMB icon
Kimberly-Clark
KMB
+$17M
2
ED icon
Consolidated Edison
ED
+$12.7M
3
EOG icon
EOG Resources
EOG
+$10.4M
4
ES icon
Eversource Energy
ES
+$9.97M
5
DGX icon
Quest Diagnostics
DGX
+$9.72M

Sector Composition

1 Healthcare 33.75%
2 Consumer Staples 26.59%
3 Technology 8.26%
4 Communication Services 7.04%
5 Financials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GIS icon
1
General Mills
GIS
$20.7B
$45.3M 2.99%
530,139
+768
+0.1% +$61.3K
MRK icon
2
Merck
MRK
$315B
$44.3M 2.92%
416,572
+506
+0.1% +$54.6K
PFE icon
3
Pfizer
PFE
$143B
$43.6M 2.87%
1,067,947
+161,346
+18% +$6.97M
CLX icon
4
Clorox
CLX
$11.9B
$42.9M 2.83%
271,342
+482
+0.2% +$72.3K
K
5
DELISTED
Kellanova
K
$42.5M 2.8%
675,936
+81,463
+14% +$5.15M
BMY icon
6
Bristol-Myers Squibb
BMY
$124B
$40.9M 2.69%
589,574
+298,474
+103% +$21.1M
CHD icon
7
Church & Dwight Co
CHD
$23.5B
$40.8M 2.69%
462,010
-36,675
-7% -$3.06M
CPB icon
8
Campbell Soup
CPB
$6.75B
$40.7M 2.68%
740,020
+78,680
+12% +$4.18M
UTHR icon
9
United Therapeutics
UTHR
$22.5B
$38.1M 2.51%
169,923
+60,639
+55% +$14.9M
GEN icon
10
Gen Digital
GEN
$16.3B
$37.2M 2.45%
2,169,286
+483,526
+29% +$9.7M
NBIX icon
11
Neurocrine Biosciences
NBIX
$17.2B
$36.7M 2.42%
362,404
+74,564
+26% +$7.76M
SJM icon
12
J.M. Smucker
SJM
$12.2B
$36M 2.37%
228,526
-19,476
-8% -$2.96M
ABBV icon
13
AbbVie
ABBV
$449B
$35.2M 2.32%
220,788
+49,873
+29% +$7.62M
JNJ icon
14
Johnson & Johnson
JNJ
$602B
$35.2M 2.32%
226,938
+83,080
+58% +$13.4M
TTWO icon
15
Take-Two Interactive
TTWO
$44.5B
$35M 2.31%
293,797
+22,335
+8% +$2.49M
NEM icon
16
Newmont
NEM
$97B
$35M 2.31%
713,594
+86,621
+14% +$4.2M
CHRW icon
17
C.H. Robinson
CHRW
$24.3B
$33.4M 2.2%
335,698
+27,980
+9% +$2.75M
HUM icon
18
Humana
HUM
$46.4B
$32.9M 2.17%
67,721
+29,451
+77% +$14.6M
HRL icon
19
Hormel Foods
HRL
$14.1B
$31.3M 2.06%
785,134
+16,678
+2% +$720K
DLTR icon
20
Dollar Tree
DLTR
$24.7B
$27.9M 1.84%
194,641
-45,336
-19% -$6.58M
SLB icon
21
SLB Ltd
SLB
$70.4B
$26.8M 1.76%
545,389
+77,623
+17% +$4.12M
CBOE icon
22
Cboe Global Markets
CBOE
$29.1B
$26.6M 1.75%
198,170
+45,007
+29% +$5.65M
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$37.8B
$25.4M 1.67%
126,760
+10,712
+9% +$2.25M
LVS icon
24
Las Vegas Sands
LVS
$30.3B
$25.1M 1.65%
436,104
+5,358
+1% +$300K
AIZ icon
25
Assurant
AIZ
$13.6B
$24.3M 1.6%
202,692
+14,756
+8% +$1.85M
1
2 3 4 5

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q1 2023 Portfolio in Review

As of Q1 2023, TOBAM held 435 positions worth $1.52B, up 0.45% from $1.51B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TOBAM's Q1 2023 filing shows 29 new, 184 increased, 112 reduced and 75 closed positions. Its largest new stake was Bausch Health: 308,486 shares worth $2.49M. The largest sale was Kimberly-Clark, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.

  • TOBAM's largest Q1 2023 buy was Bausch Health: 308,486 shares worth $2.49M.
  • TOBAM added most to Bristol-Myers Squibb in Q1 2023, an estimated $21.1M increase.
  • TOBAM's biggest Q1 2023 reduction was Kimberly-Clark, cutting an estimated $17M.
  • TOBAM fully exited Stantec in Q1 2023, selling an estimated $1.26M.
  • TOBAM's ten largest holdings make up 27% of its $1.52B portfolio in Q1 2023.
  • TOBAM opened 29 new positions and closed 75 in Q1 2023.
  • TOBAM's portfolio value rose 0.45% quarter-over-quarter to $1.52B.

Based on TOBAM's 13F filing for Q1 2023, filed 3 May 2023.